AI assistant
Sending…
AMGEN INC — Director's Dealing 2018
Feb 3, 2018
29819_dirs_2018-02-02_7afeacde-ebc3-4be3-be0a-fbd850ae266b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2017-12-31
Reporting Person: HOLLEY CHARLES M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-15 | Common Stock | G | 615 | — | Disposed | 615 | Direct |
| 2017-05-15 | Common Stock | G | 615 | — | Acquired | 645 | Indirect |
| 2017-05-16 | Common Stock | G | 615 | — | Disposed | 0 | Direct |
| 2017-05-16 | Common Stock | G | 615 | — | Acquired | 1260 | Indirect |
More from AMGEN INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 1
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7